Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


TSXV:VIV - Post by User

<< Previous
Bullboard Posts
Next >>
Post by DrJayseron Aug 05, 2020 12:39pm
120 Views
Post# 31367474

first commercial sale of OxC-beta for livestock, in Thailand

first commercial sale of OxC-beta for livestock, in Thailand

OTTAWA, ONTARIO, June 25, 2013 - Avivagen Inc. (TSXV:VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces its first commercial sale of OxC-beta for livestock, in Thailand.

Avivagen announces that OxC-beta is now commercially available in the Kingdom of Thailand and receipt of payment for its first commercial order. Avivagen believes that OxC-beta will be a valuable tool for producers in the aquaculture and livestock industries of that country and is pleased to make its novel and proprietary product available. Thailand has large aquaculture, poultry and pork industries that collectively produce approximately 3.4 million metric tons of such meats each year

<< Previous
Bullboard Posts
Next >>